Axitinib

Spécifications

319460-85-0Numéro CAS

638-771-6Numéro CE

N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamideNom IUPAC

C22H18N4OSFormule chimique

386.5 g/molMasse molaire

Axitinib; 319460-85-0; Inlyta; AG-13736; axitinibum; C9LVQ0YUXG; DTXSID3049049; AG013736; NSC-757441; N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide; N-methyl-2-({3-[(E)-2-(pyridin-2-yl)ethenyl]-1H-indazol-6-yl}sulfanyl)benzamide; DTXCID8028975; CHEBI:66910; Benzamide, N-methyl-2-((3-((E)-2-(2-pyridinyl)ethenyl)-1H-indazol-6-yl)thio)-; N-methyl-2-({3-[(1E)-2-(pyridin-2-yl)ethenyl]-1H-indazol-6-yl}sulfanyl)benzamide; Benzamide, N-methyl-2-((3-((1E)-2-(2-pyridinyl)ethenyl)-1H-indazo)-6-yl)thio)-; N-methyl-2-((3-((E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide; RefChem:58911; L01XE17; AG-013736; (E)-N-Methyl-2-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide; AG 013736; MFCD09837898; N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide; NSC757441; NCGC00241108-01; N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide; C22H18N4OS; N-methyl-2-({3-[(E)-2-(pyridin-2-yl)vinyl]-1H-indazol-6-yl}sulfanyl)benzamide; N-METHYL-2-(3-((E)-2-PYRIDIN-2-YL-VINYL)-1H-INDAZOL-6-YLSULFANYL)-BENZAMIDE; Axitinib [USAN]; CAS-319460-85-0; N-Methyl-2-[[3-[(1Z)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide; UNII-C9LVQ0YUXG; Axitinib [USAN:INN:JAN]; 4agc; 1528729-60-3; (E)-N-methyl-2-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-ylthio)benzamide; Axitinib (Standard); Inlyta (TN); S1005; 4ag8; Axitinib (JAN/USAN); AXITINIB [INN]; AXITINIB [JAN]; AXITINIB [MI]; AXITINIB [VANDF]; AXITINIB [MART.]; AG-013736;Axitinib; AXITINIB [WHO-DD]; Axitinib,AG-013736; N-methyl-2-[[3-[(E)-2-(2-pyridyl)vinyl]-1H-indazol-6-yl]sulfanyl]benzamide; MLS006010164; SCHEMBL172918; AXITINIB [ORANGE BOOK]; GTPL5659; orb1225317; orb1308579; Axitinib, >=98% (HPLC); CHEMBL1289926; N-methyl-2-[[3-[2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide; SCHEMBL22930506; SCHEMBL29349703; SCHEMBL29384419; BDBM25117; CHEBI:94568; EX-A337; GLXC-90095; HMS5079A03; Tox21_113597; EBC-17083; HY-10065R; NSC799341; AKOS015902898; Tox21_113597_1; AC-1539; CCG-264772; CS-0116; DB06626; EBC-219024; FA18036; KS-1448; NSC 757441; NSC-799341; SDCCGSBI-0646925.P002; NCGC00241108-04; NCGC00241108-06; NCGC00241108-11; BP-43627; HY-10065; SMR002530046; SY067130; A9435; NS00005657; SW219464-1; D03218; AB01274739-01; AB01274739_02; EN300-26869010; F407015; SR-01000941566; Q4830631; SR-01000941566-1; BRD-K29905972-001-01-4; BRD-K29905972-001-02-2; BRD-K29905972-001-06-3; BRD-K29905972-001-08-9; BRD-K29905972-001-10-5; BRD-K29905972-001-11-3; BRD-K29905972-001-12-1; Z2216885372; N-Methyl-2-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide; AG 013736; (E)-N-methyl-2-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide; BENZAMIDE, N-METHYL-2-((3-((1E)-2-(2-PYRIDINYL)ETHENYL)-1H-INDAZOL-6-YL)THIO)-; N-Methyl-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide; N-METHYL-2((3-((1E0-2-(PYRIDIN-2-YL)ETHENYL)-1H-INAZOL-6-YLSUFANYL)BENZAMIDE; N-Methyl-2-({3-[(E)-2-(pyridin-2-yl)ethen-1-yl]-1H-indazol-6-yl}sulfanyl)benzamide; N-methyl-2-({3-[(E)-2-pyridin-2-ylethenyl]-2H-indazol-6-yl}sulfanyl)benzamide; N-methyl-2-[[3-[(E)-2-(2-pyridyl)vinyl]-2H-indazol-6-yl]sulfanyl]benzamideSynonymes